Temodal and disease progression 
Temodal and disease progression Patient Reports February 12, 2012
Temodal Side Effects Report #5557069-0
Temodal side effect was reported by a Physician from JAPAN on Dec 06, 2007. Male patient, 71 years of age, weighting 114.6 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: activities of daily living impaired, depressed level of consciousness, disease progression, lymphocyte count decreased, pneumonia
, tumour haemorrhage. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, TAKEPRON OD, AMLODIN, DIOVAN, ASPIRIN, URSO, PREDNISOLONE, AZULFIDINE EN. Patient died on 05/25/2007.Temodal Side Effects Report #5578567-X
Temodal side effect was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 69 years of age, weighting 108.0 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, disseminated intravascular coagulation, malignant oligodendroglioma, melaena, multi-organ failure, shock, thrombocytopenia. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with ONCOVIN, NATULAN, DEPAKENE, ZONISAMIDE. Patient died on 11/07/2006.
Temodal Side Effects Report #5766170-8
Temodal side effect was reported by a Physician from JAPAN on June 04, 2008. Male patient, 69 years of age, weighting 108.0 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, loss of consciousness, melaena, multi-organ failure, oligodendroglioma, shock, thrombocytopenia. Temodal dosage: 150 MG/M2;QD;PO. During the same period patient was treated with ONCOVIN, NATULAN, DEPAKENE, EXCEGRAN. Patient died on 11/07/2006.
Temodal Side Effects Report #5818358-5
Temodal side effect was reported by a Physician from JAPAN on July 15, 2008. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with oligodendroglioma, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, disease progression, disseminated intravascular coagulation, pneumonia
, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO. During the same period patient was treated with COTRIM, ZOFRAN, PRIMPERAN, LENDORMIN D, EXCEGRAN. Patient died on 03/06/2007.Temodal Side Effects Report #6008366-6
Temodal side effect was reported by a Physician from JAPAN on Dec 08, 2008. Male patient, 48 years of age, weighting 105.8 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, condition aggravated, disease progression, disseminated intravascular coagulation, platelet count decreased, pneumonia
, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2;QD;PO; 200 MG/M2;QD;PO; 200 MG/M2;QD;PO. During the same period patient was treated with COTRIM, ZOFRAN, PRIMPERAN, LENDORMIN D, EXCEGRAN. Patient died on 03/06/2007.Temodal Side Effects Report #5258242-1
Temodal side effect was reported by a Health Professional from CANADA on Feb 20, 2007. Female patient, 38 years of age, weighting 163.0 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: cough, diabetes insipidus
, disease progression, haemoglobin decreased, hypothyroidism, nausea , platelet count decreased, rhinorrhoea, sciatica . Temodal dosage: unknown. During the same period patient was treated with DECADRON, KYTRIL. Patient recovered.Temodal Side Effects Report #5603428-7
Temodal side effect was reported by a Physician from JAPAN on Jan 21, 2008. Female patient, 29 years of age, weighting 97.00 lb, was diagnosed with oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: brain oedema, disease progression, lymphocyte count decreased, neoplasm recurrence, pneumonia aspiration, sepsis
. Temodal dosage: 75 MG;QD;PO, 200 MG/M2;QD;PO. During the same period patient was treated with ALEVIATIN, UNASYN, FLUMARIN, ZONISAMIDE, TAKEPRON OD, MAGNESIUM OXIDE, NASEA. Patient was hospitalized. Patient died.Temodal Side Effects Report #5408383-0
Temodal side effect was reported by a Physician from JAPAN on July 30, 2007. Male patient, 20 years of age, weighting 114.6 lb, was diagnosed with oligodendroglioma, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood lactate dehydrogenase increased, disease progression, disseminated intravascular coagulation, metastases to liver, metastases to lung, metastases to skin, platelet count decreased. Temodal dosage: PO, 150 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, NASEA, BROCIN CODEINE, DECADRON, FAMOTIDINE, MAGMITT, PREDONINE. Patient died on 02/04/2007.
Temodal Side Effects Report #5226221-6
Temodal side effect was reported by a Physician from JAPAN on Jan 22, 2007. Male patient, 69 years of age, weighting 108.0 lb, was diagnosed with neoplasm recurrence, oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, melaena, multi-organ failure, shock, thrombocytopenia. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with ACNU, ONCOVIN, NATULAN. Patient died on 11/07/2006.
Temodal Side Effects Report #5223599-4
Temodal side effect was reported by a Physician from FRANCE on Jan 15, 2007. Female patient, 81 years of age, weighting 167.6 lb, was diagnosed with metastatic malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: asthenia, bacterial infection
, disease progression, febrile neutropenia, liver disorder, serratia infection, thrombocytopenia. Temodal dosage: 280 MG; QD; PO. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5306402-3
Temodal side effect was reported by a Physician from FRANCE on Apr 16, 2007. Female patient, 81 years of age, weighting 167.6 lb, was diagnosed with metastatic malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: asthenia, bacillus infection, bacterial infection
, blood culture positive, disease progression, febrile neutropenia, liver disorder, rash . Temodal dosage: 280 MG; QD; PO. During the same period patient was treated with CLAFORAN, GENTAMICIN, FORTUM, AMIKLIN, TICARPEN, PEFLACIN, CEFTRIAXONE, NEUPOGEN. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5318456-9
Temodal side effect was reported by a Physician from FRANCE on Apr 26, 2007. Female patient, 81 years of age, weighting 167.6 lb, was diagnosed with metastatic malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: asthenia, blood culture positive, disease progression, liver disorder, neutropenic infection, rash
, serratia infection, thrombocytopenia. Temodal dosage: 280 MG; QD; PO. During the same period patient was treated with CLAFORAN, GENTAMICIN, FORTUM, AMIKLIN, TICARPEN, PEFLACIN, CEFTRIAXONE, NEUPOGEN. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5501395-8
Temodal side effect was reported by a Physician from SWITZERLAND on Oct 19, 2007. Male patient, 73 years of age, was diagnosed with metastases to central nervous system and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression. Temodal dosage: 130 MG; PO. Patient was hospitalized. Patient died on 10/04/2007.
Temodal Side Effects Report #5192069-4
Temodal side effect was reported by a Physician from FRANCE on Dec 08, 2006. Male patient, 70 years of age, was diagnosed with metastases to central nervous system and was treated with Temodal. After drug was administered, patient experienced the following side effects: abdominal pain
, acne , amyotrophy, chills, coordination abnormal, cough, diarrhoea, disease progression, dyspnoea exertional. Temodal dosage: unknown. Patient was hospitalized. Patient died on 03/31/2003.Temodal Side Effects Report #5191029-7
Temodal side effect was reported by a Physician from FRANCE on Dec 14, 2006. Male patient, 63 years of age, was diagnosed with metastases to central nervous system and was treated with Temodal. After drug was administered, patient experienced the following side effects: alopecia, asthenia, disease progression, febrile neutropenia, phlebitis. Temodal dosage: unknown. During the same period patient was treated with CISPLATIN. Patient was hospitalized. Patient died on 06/15/2003.
Temodal Side Effects Report #5631829-X
Temodal side effect was reported by a Physician from SWITZERLAND on Jan 31, 2008. Female patient, 58 years of age, was diagnosed with metastases to central nervous system, non-small cell lung cancer metastatic and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, disease progression, gamma-glutamyltransferase increased, lymphocyte percentage decreased, malignant ascites, oral candidiasis. Temodal dosage: 135 MG;QD;PO. During the same period patient was treated with PANTOZOL, FORTECORTIN, CODEIN KNOLL, DAFALGAN, MORPHINE, TEMESTA, VALERIAN. Patient was hospitalized. Patient died on 01/07/2008.
Temodal Side Effects Report #5650437-8
Temodal side effect was reported by a Physician from SWITZERLAND on Feb 26, 2008. Female patient, 58 years of age, was diagnosed with metastases to central nervous system, non-small cell lung cancer metastatic and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood glucose increased, blood lactate dehydrogenase increased, blood sodium decreased, disease progression, gamma-glutamyltransferase increased, lymphocyte percentage decreased, malignant ascites, oral candidiasis. Temodal dosage: 135 MG QD PO. During the same period patient was treated with PANTOZOL, FORTECORTIN, CODEIN KNOLL, DAFALGAN, MORPHINE, TEMESTA, VALERIAN. Patient was hospitalized. Patient died on 01/07/2008.
Temodal Side Effects Report #5363465-7
Temodal side effect was reported by a Physician from JAPAN on June 11, 2007. Male patient, 24 years of age, weighting 94.80 lb, was diagnosed with medulloblastoma recurrent and was treated with Temodal. After drug was administered, patient experienced the following side effects: brain stem syndrome, disease progression, pneumonia
, respiratory disorder. Temodal dosage: 200 MG/M2; QD; PO. During the same period patient was treated with RANIMUSTINE, METHOTREXATE, IFOMIDE, LOXONIN, PREDNISOLONE. Patient was hospitalized. Patient died on 02/21/2007.Temodal Side Effects Report #5527909-X
Temodal side effect was reported by a Physician from JAPAN on Nov 20, 2007. Male patient, 24 years of age, weighting 94.80 lb, was diagnosed with medulloblastoma recurrent and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, neoplasm progression, pneumonia
, respiratory disorder, staphylococcal infection . Temodal dosage: PO; 200 MG/M2;QD; PO. During the same period patient was treated with RANIMUSTINE, METHOTREXATE, IFOSFAMIDE, LOXONIN, PREDNISOLONE. Patient was hospitalized. Patient died on 02/21/2007.Temodal Side Effects Report #5548332-8
Temodal side effect was reported by a Physician from JAPAN on Dec 03, 2007. Male patient, 63 years of age, weighting 156.5 lb, was diagnosed with malignant oligodendroglioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, myelodysplastic syndrome, neutrophil count decreased, platelet count decreased, white blood cell count decreased. Temodal dosage: PO; 200 MG/M2; QD; PO150 MG/M2; QD; PO. During the same period patient was treated with DEPAKENE. Patient was hospitalized. Patient died on 11/27/2007.
Temodal Side Effects Report #4635633-0
Temodal side effect was reported by a Pharmacist from on Apr 04, 2005. Male patient was diagnosed with malignant melanoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, disease progression, hypercalcaemia. Temodal dosage: unknown. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5500043-0
Temodal side effect was reported by a Physician from JAPAN on Oct 16, 2007. Male patient, 76 years of age, weighting 66.14 lb, was diagnosed with malignant glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: anorexia, disease progression, malnutrition, pneumonia
. Temodal dosage: 80 MG; QD; PO. During the same period patient was treated with BAKTAR, DEPAKENE. Patient was hospitalized. Patient died on 01/01/2007.Temodal Side Effects Report #5660490-3
Temodal side effect was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Male patient, 76 years of age, weighting 121.3 lb, was diagnosed with malignant glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, malignant glioma. Temodal dosage: 150 MG/M2; ; PO, 320 MG; QD; PO. During the same period patient was treated with HYPNOVEL, SCOPOLAMINE, MORPHINE. Patient died on 09/12/2007.
Temodal Side Effects Report #5834942-7
Temodal side effect was reported by a Physician from FRANCE on Aug 01, 2008. Male patient, 80 years of age, weighting 167.6 lb, was diagnosed with lymphoma
and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, aplasia, disease progression, lung disorder, lymphoma . Temodal dosage: 285 MG; QD; PO. During the same period patient was treated with METHOTREXATE, IDARUBICIN, IFOSFAMIDE, DIFFU K, LOVENOX. Patient was hospitalized. Patient died on 07/30/2008.Temodal Side Effects Report #5892186-7
Temodal side effect was reported by a Physician from FRANCE on Sept 12, 2008. Male patient, 80 years of age, weighting 167.6 lb, was diagnosed with lymphoma
and was treated with Temodal. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, aplasia, disease progression, neoplasm recurrence. Temodal dosage: 285 MG; QD; PO. During the same period patient was treated with METHOTREXATE, IDARUBICIN, IFOSFAMIDE, DIFFU K, LOVENOX. Patient was hospitalized. Patient died on 07/30/2008.Temodal Side Effects Report #5710504-7
Temodal side effect was reported by a Pharmacist from JAPAN on Apr 08, 2008. Female patient, 59 years of age, weighting 105.8 lb, was diagnosed with lymphoma
and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspiration, disease progression, disseminated intravascular coagulation, electrolyte imbalance, enterococcal infection, ill-defined disorder, lymphoma , pancytopenia, pneumonia bacterial. Temodal dosage: 75 MG/M2,QD.PO; 150 MG/M2;QD;PO. During the same period patient was treated with BAKTAR, BENAMBAX, RADEN, RITALIN, CHOLINE, PREDNISOLONE. Patient was hospitalized. Patient died on 06/27/2007.Temodal Side Effects Report #5557380-3
Temodal side effect was reported by a Physician from JAPAN on Dec 04, 2007. Male patient, 76 years of age, weighting 66.14 lb, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: anorexia, disease progression, malnutrition, pneumonia
. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with BAKTAR, DEPAKENE. Patient was hospitalized. Patient died on 10/06/2007.Temodal Side Effects Report #5663626-3
Temodal side effect was reported by a Physician from CANADA on Mar 04, 2008. Female patient, child 6 years of age, weighting 44.09 lb, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: anorexia, computerised tomogram abnormal, disease progression, drooling, facial paresis, headache
, hypersomnia, hypoaesthesia, paraesthesia. Temodal dosage: 20 MG;QD;PO. During the same period patient was treated with DEXAMETHASONE, ONDANSETRON, RANITIDINE, SEPTRA. Patient died on 08/10/2007.Temodal Side Effects Report #4867046-0
Temodal side effect was reported by a Physician from FRANCE on Dec 14, 2005. Female patient, child 5 years of age, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: arthralgia, chondroma, disease progression, gait disturbance, osteolysis. Temodal dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died.
Temodal Side Effects Report #4892031-2
Temodal side effect was reported by a Physician from FRANCE on Jan 12, 2006. Male patient, child 5 years of age, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: arthralgia, chondroma, disease progression, gait disturbance, osteolysis. Temodal dosage: unknown. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient died on 12/10/1998.
Temodal Side Effects Report #5445944-7
Temodal side effect was reported by a Physician from JAPAN on Aug 27, 2007. Male patient, 45 years of age, weighting 143.3 lb, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, gamma-glutamyltransferase increased, glioma, hepatic function abnormal, inflammation, liver disorder, lymphocyte count decreased, malignant neoplasm progression. Temodal dosage: 240 MG; QD; PO, 340 MG; QD; PO. During the same period patient was treated with NIDRAN, METHOTREXATE, IFOSFAMIDE, CISPLATIN, ETOPOSIDE, BAKTAR, EXCEGRAN. Patient died on 01/05/2007.
Temodal Side Effects Report #5493121-6
Temodal side effect was reported by a Physician from JAPAN on Oct 11, 2007. Female patient, 39 years of age, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression. Temodal dosage: unknown. Patient died on 01/01/2007.
Temodal Side Effects Report #5748749-2
Temodal side effect was reported by a Physician from JAPAN on May 16, 2008. Female patient, 36 years of age, weighting 101.4 lb, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, eating disorder
, malnutrition, neoplasm progression, paralysis , pneumonia aspiration. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with MUCOSTA, MAGNESIUM OXIDE, DEPAKENE, SP TROCHE, GLYSENNID. Patient died on 02/08/2007.Temodal Side Effects Report #5989589-9
Temodal side effect was reported by a Physician from JAPAN on Dec 01, 2008. Female patient, 36 years of age, weighting 101.4 lb, was diagnosed with glioma and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspiration, disease progression, dysphagia, eating disorder
, malnutrition, paralysis . Temodal dosage: 150 MG/M2;QD;PO : 150 MG/M2;QD;PO. During the same period patient was treated with MUCOSTA, MAGNESIUM OXIDE, DEPAKENE, SP TROCHE, PURSENNID. Patient died on 02/08/2007.Temodal Side Effects Report #6023801-5
Temodal side effect was reported by a Physician from JAPAN on Dec 16, 2008. Male patient, 75 years of age, weighting 108.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: abdominal distension, altered state of consciousness, blood chloride decreased, blood glucose increased, blood sodium decreased, brain oedema, c-reactive protein increased, disease progression, disseminated intravascular coagulation. Temodal dosage: 300 MG; QD; PO. During the same period patient was treated with RINDERON, DEPAKENE, ACINON, NASEA OD. Patient died on 01/18/2007.
Temodal Side Effects Report #5428992-2
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, 74 years of age, weighting 114.6 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: cardiac failure, convulsion, deep vein thrombosis
, disease progression, vena cava thrombosis. Temodal dosage: 100 MG;QD; PO; 220 MG;QD; PO ; 300 MG;QD; PO. During the same period patient was treated with SIGMART, SELBEX, METOPROLOL TARTRATE, FLIVAS, PHENYTOIN CAP. Patient died on 05/20/2007.Temodal Side Effects Report #5474831-3
Temodal side effect was reported by a Physician from JAPAN on Sept 20, 2007. Male patient, 74 years of age, weighting 114.6 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: cardiac failure, convulsion, deep vein thrombosis
, disease progression, hemiplegia, immobile, vena cava thrombosis. Temodal dosage: 100 MG; QD; PO; 220 MG; QD; PO; 300 MG; QD; PO. During the same period patient was treated with SIGMART, SELBEX, METOPROLOL TARTRATE, FLIVAS, PHENYTOIN CAP. Patient died on 05/20/2007.Temodal Side Effects Report #5535114-6
Temodal side effect was reported by a Physician from JAPAN on Nov 27, 2007. Male patient, 74 years of age, weighting 97.00 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bronchitis
, disease progression, glioblastoma multiforme. Temodal dosage: PO; 150 MG/M2;QD;PO. During the same period patient was treated with NASEA OD, SELENICA R. Patient was hospitalized. Patient died on 12/06/2006.Temodal Side Effects Report #6112253-2
Temodal side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, 73 years of age, weighting 88.18 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lymphocyte count decreased, platelet count decreased, pneumonia
. Temodal dosage: 154 MG/M2/;QD;PO : 210 MG/M2;QD;PO : 210 MG/M2;QD;PO : 210 MG;M2;QD;PO. During the same period patient was treated with BAKTAR, NASEA OD, NAUZELIN, MAGNESIUM OXIDE. Patient was hospitalized. Patient died on 07/28/2008.Temodal Side Effects Report #4592677-5
Temodal side effect was reported by a Physician from on Feb 10, 2005. Male patient, 72 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, neoplasm progression, respiratory failure, somnolence, thrombocytopenia. Temodal dosage: 400 MG QD ORAL; SEE IMAGE. During the same period patient was treated with GLIOBLASTOMAME, HAPARINECTABLE, METAMIZOLE. Patient was hospitalized. Patient died on 12/07/2004.
Temodal Side Effects Report #5192132-8
Temodal side effect was reported by a Physician from JAPAN on Dec 13, 2006. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, enterocolitis bacterial, gastroenteritis escherichia coli, immune system disorder. Temodal dosage: unknown. Patient was hospitalized. Patient died on 12/02/2006.
Temodal Side Effects Report #5445942-3
Temodal side effect was reported by a Physician from JAPAN on Aug 28, 2007. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: c-reactive protein increased, condition aggravated, delirium, disease progression, enterocolitis bacterial, escherichia infection, glioblastoma multiforme, hydrocephalus
, infection in an immunocompromised host. Temodal dosage: unknown. During the same period patient was treated with RINDERON, PHENOBARBITAL. Patient was hospitalized. Patient died on 12/02/2006.Temodal Side Effects Report #5616720-7
Temodal side effect was reported by a Physician from JAPAN on Jan 29, 2008. Male patient, 71 years of age, weighting 121.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, delirium, disease progression, enterocolitis bacterial, escherichia infection, hydrocephalus
, immune system disorder, platelet count decreased. Temodal dosage: unknown. During the same period patient was treated with BETAMETHASONE, PHENOBAL. Patient was hospitalized. Patient died on 12/02/2006.Temodal Side Effects Report #5937813-0
Temodal side effect was reported by a Physician from JAPAN on Oct 23, 2008. Female patient, 70 years of age, weighting 112.4 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, glioblastoma multiforme, meningioma, pyelonephritis, pyrexia. Temodal dosage: 150 MG/M2; QD; PO, 200 MG/M2; QD; PO, ;PO. Patient recovered.
Temodal Side Effects Report #5960476-5
Temodal side effect was reported by a Physician from JAPAN on Nov 14, 2008. Female patient, 70 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, toxic skin eruption. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with ZONISAMIDE, PRIMPERAN, COTRIM, LENDORMIN, NASEA OD, AMARYL, HUMULIN R, NOVOLIN R. Patient was hospitalized. Patient died on 01/01/2008.
Temodal Side Effects Report #6025244-7
Temodal side effect was reported by a Physician from JAPAN on Dec 19, 2008. Female patient, 70 years of age, weighting 112.4 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, disease recurrence, meningioma, pyelonephritis, pyrexia. Temodal dosage: 150 MG/M2; QD; PO, 200 MG/M2, QD; PO. Patient recovered.
Temodal Side Effects Report #5846257-1
Temodal side effect was reported by a Physician from AUSTRALIA on Aug 11, 2008. Male patient, 69 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: dehydration, disease progression, hypophagia, mobility decreased, mucosal inflammation. Temodal dosage: 350 MG; QD; PO. During the same period patient was treated with DOXORUBICIN, METFORMIN, DEXAMETHASONE, COVERSYL, BACTRIM. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5353141-9
Temodal side effect was reported by a Physician from JAPAN on June 01, 2007. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme, antifungal prophylaxis and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, hepatic function abnormal, neoplasm progression, performance status decreased, pyrexia, rash
, vomiting. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with BACTRIM, VALPROATE, FAMOTIDINE, GLYCEOL, DECADRON, PREDNISOLONE, WAKOBITAL, MAGMITT. Patient died on 05/15/2007.Temodal Side Effects Report #5862263-5
Temodal side effect was reported by a Physician from JAPAN on Aug 22, 2008. Male patient, 68 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme, antifungal prophylaxis and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, hepatic function abnormal, pyrexia, rash
, vomiting. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with BACTRIM, DEPAKENE, FAMOTIDINE, GLYCEOL, DECADRON SRC, WAKOBITAL, MAGMITT. Patient died on 05/15/2007.Temodal Side Effects Report #5689813-6
Temodal side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 67 years of age, weighting 101.4 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, convulsion, disease progression, hydrocephalus
, hypoproteinaemia, lymphocyte count decreased, pneumocystis jiroveci pneumonia, respiratory failure. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with ZOFRAN, NIVADIL, SIMVASTATIN, CARDENALIN, GASTER D, ZONISAMIDE, WAKOBITAL, PREDNISOLONE. Patient was hospitalized. Patient died on 12/03/2007.Temodal Side Effects Report #5364295-2
Temodal side effect was reported by a Physician from JAPAN on June 14, 2007. Male patient, 66 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme, neoplasm recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, intracranial tumour haemorrhage. Temodal dosage: unknown. During the same period patient was treated with NATULAN, CYMERIN, ONCOVIN. Patient died on 04/25/2007.
Temodal Side Effects Report #5578527-9
Temodal side effect was reported by a Physician from JAPAN on Dec 21, 2007. Male patient, 66 years of age, weighting 110.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, intracranial tumour haemorrhage. Temodal dosage: 150 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with NATULAN, CYMERIN, ONCOVIN, DEPAKENE. Patient died on 04/25/2007.
Temodal Side Effects Report #5361145-5
Temodal side effect was reported by a Physician from JAPAN on June 08, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure, disease progression, gastrointestinal haemorrhage, glioblastoma, platelet count decreased, pneumocystis jiroveci pneumonia. Temodal dosage: 75 MG/M2; QD; PO. During the same period patient was treated with VALPROATE, TAGAMET, BETAMETHASONE, NASEA, DOGMATYL, MAALOX FAST BLOCKER, MAGLAX, PURSENNID. Patient died on 05/09/2007.
Temodal Side Effects Report #5582800-8
Temodal side effect was reported by a Physician from JAPAN on Dec 21, 2007. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, blood beta-d-glucan increased, cardiac failure, condition aggravated, disease progression, gastrointestinal haemorrhage, hyperkalaemia. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with BETAMETHASONE, DEPAKENE R, TAGAMET, NASEA, DOGMATYL, MAALOX, MAGLAX, GLYSENNID. Patient died on 05/09/2007.
Temodal Side Effects Report #5660491-5
Temodal side effect was reported by a Physician from JAPAN on Feb 29, 2008. Female patient, 65 years of age, weighting 136.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: cardiomegaly, disease progression. Temodal dosage: 75 MG/M2; QD; PO, 150 MG/M2; QD; PO, 200 MG/M2; QD; PO, 200 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, NAUZELIN, MAGMITT, PREDONINE, TAKEPRON. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5913560-6
Temodal side effect was reported by a Physician from JAPAN on Sept 29, 2008. Female patient, 65 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: anaemia, blood albumin decreased, blood alkaline phosphatase increased, cardiac failure, disease progression, gastrointestinal haemorrhage, hyperkalaemia, lymphocyte count decreased, neutrophil count decreased. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with BETAMETHASONE, DEPAKENE, TAGAMET, NASEA, DOGMATYL, MAALOX, MAGLAX, PURSENNID. Patient died on 05/09/2007.
Temodal Side Effects Report #5480987-9
Temodal side effect was reported by a Physician from JAPAN on Sept 28, 2007. Male patient, 64 years of age, weighting 163.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: activities of daily living impaired, decreased appetite, disease progression, hepatic function abnormal, pneumonia
. Temodal dosage: 200 MG/M2;QD;PO. During the same period patient was treated with KYTRIL, NAUZELIN, FAMOTIDINE. Patient was hospitalized. Patient died on 05/12/2007.Temodal Side Effects Report #5767300-4
Temodal side effect was reported by a Physician from JAPAN on June 02, 2008. Male patient, 64 years of age, weighting 163.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: activities of daily living impaired, decreased appetite, disease progression, hepatic function abnormal, intracranial tumour haemorrhage, pneumonia
. Temodal dosage: 360 MG/M2;QD;PO; 340 MG/M2;QD;PO. During the same period patient was treated with KYTRIL, NAUZELIN, FAMOTIDINE. Patient was hospitalized. Patient died on 05/12/2007.Temodal Side Effects Report #5317860-2
Temodal side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, meningioma malignant, platelet count decreased, pneumonia
, respiratory failure, shock, white blood cell count decreased. Temodal dosage: unknown. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5429903-6
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2007. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, lung disorder, platelet count decreased, pneumonia
, respiratory failure, shock, white blood cell count decreased. Temodal dosage: 250 MG; QD; PO, 250 MG; QD; PO, 150 MG/M2; QD; PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, EXCEGRAN, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5613348-X
Temodal side effect was reported by a Physician from JAPAN on Jan 22, 2008. Male patient, 63 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: brain neoplasm, disease progression, loss of consciousness, lung disorder, meningioma malignant, platelet count decreased, pneumonia
. Temodal dosage: 250 MG; QD; PO; 150 MG/M2;QD;PO. During the same period patient was treated with FERON, CYMERIN, TEGRETOL, ZONISAMIDE, PENTCILLIN, SULPERAZON. Patient died on 10/14/2006.Temodal Side Effects Report #5203408-X
Temodal side effect was reported by a Physician from JAPAN on Dec 26, 2006. Female patient, 60 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, convulsion, disease progression, gamma-glutamyltransferase increased. Temodal dosage: unknown. During the same period patient was treated with DEPAKENE. Patient died on 12/24/2006.
Temodal Side Effects Report #5345776-4
Temodal side effect was reported by a Physician from JAPAN on May 29, 2007. Female patient, 60 years of age, weighting 132.3 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, hepatic function abnormal. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with FERON, NIDRAN, BAKTAR, RINDERON, NOVORAPID. Patient died on 01/31/2007.
Temodal Side Effects Report #5776555-1
Temodal side effect was reported by a Physician from JAPAN on June 11, 2008. Male patient, 60 years of age, weighting 147.7 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood pressure diastolic decreased, disease progression, disseminated intravascular coagulation, platelet count decreased, pneumonia aspiration, sepsis
, vomiting, white blood cell count decreased. Temodal dosage: 150 MG/M2;QD;PO; 100 MG/M2;QD;PO. During the same period patient was treated with EXCEGRAN, SELENICA, FAMOTIDINE, MYSTAN. Patient died on 05/14/2008.Temodal Side Effects Report #5859194-3
Temodal side effect was reported by a Physician from JAPAN on Aug 21, 2008. Female patient, 60 years of age, weighting 167.6 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: condition aggravated, disease progression, hydrocephalus
. Temodal dosage: 75 MG/M2 QD PO ; 150 MG/M2 QD PO. During the same period patient was treated with COTRIM, KYTRIL, TEGRETOL, GASTER D. Patient died on 09/05/2007.Temodal Side Effects Report #5109724-4
Temodal side effect was reported by a Pharmacist from CANADA on Aug 30, 2006. Male patient, 57 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: deafness unilateral, disease progression. Temodal dosage: unknown. Patient recovered.
Temodal Side Effects Report #5278365-0
Temodal side effect was reported by a Consumer or non-health professional from JAPAN on Mar 15, 2007. Male patient, 54 years of age, weighting 163.1 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, hydrocephalus
. Temodal dosage: unknown. During the same period patient was treated with EXCEGRAN, RINDERON, GASTER, PURSENNID. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5728562-2
Temodal side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 24, 2008. Male patient, 54 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: aplastic anaemia, disease progression, leukopenia, pancytopenia, thrombocytopenia. Temodal dosage: 160 MG; QD; PO. During the same period patient was treated with BETAMETHASONE, SUCRALPHATE, ACETAMINOPHEN, ZOPIKLON, ONDANSETRON, CIPROFLOXACIN, FLUCONAZOLE, ACYCLOVIR. Patient was hospitalized. Patient died on 01/01/2008.
Temodal Side Effects Report #5192159-6
Temodal side effect was reported by a Health Professional from JAPAN on Dec 14, 2006. Female patient, 50 years of age, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression. Temodal dosage: 200 MG; QD; PO. Patient died.
Temodal Side Effects Report #5674071-9
Temodal side effect was reported by a Physician from JAPAN on Mar 10, 2008. Male patient, 47 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: asthenia, disease progression, hypogammaglobulinaemia, nasopharyngitis, pneumocystis jiroveci pneumonia, pulmonary fibrosis
. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with TEGRETOL, GLYCEOL, RINDERON, FAMOTIDINE, ZOFRAN, MENILET, ACHROMYCIN, ALESION. Patient died on 03/29/2007.Temodal Side Effects Report #5967985-3
Temodal side effect was reported by a Physician from JAPAN on Nov 19, 2008. Male patient, 47 years of age, weighting 165.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disease progression, immunosuppression, nasopharyngitis, pneumocystis jiroveci pneumonia, pulmonary fibrosis
, white blood cell count decreased. Temodal dosage: 75 MG/M2; QD, PO. During the same period patient was treated with TEGRETOL, GLYCEOL, CELESTONE, FAMOTIDINE, ZOFRAN, MENILET, ACHROMYCIN, ALESION. Patient died on 03/29/2007.Temodal Side Effects Report #6029364-2
Temodal side effect was reported by a Physician from AUSTRIA on Dec 19, 2008. Male patient, 45 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, nuclear magnetic resonance imaging brain abnormal. Temodal dosage: 150 MG;QD;PO. During the same period patient was treated with KEPPRA, LAMICTAL, NEXIUM, MYOLASTAN, LOVENOX, DOMINALTE, CELEBREX. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5834989-0
Temodal side effect was reported by a Physician from JAPAN on July 29, 2008. Male patient, 44 years of age, weighting 120.2 lb, was diagnosed with glioblastoma multiforme, disease recurrence and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, disease progression, gamma-glutamyltransferase increased, lymphocyte count decreased. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with GLYCEREB, PHENOBARBITAL, EXCEGRAN, BETAMETHASONE, GASTER D. Patient died on 01/10/2007.
Temodal Side Effects Report #5935239-7
Temodal side effect was reported by a Physician from JAPAN on Oct 23, 2008. Male patient, 44 years of age, weighting 120.2 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, disease progression, gamma-glutamyltransferase increased, glioblastoma, lymphocyte count decreased. Temodal dosage: 150 MG/M2;QD;PO. During the same period patient was treated with GLYCEREB, PHENOBARBITAL, EXCEGRAN, CELESTONE, GASTER D. Patient died on 01/10/2007.
Temodal Side Effects Report #5766898-X
Temodal side effect was reported by a Physician from JAPAN on June 05, 2008. Female patient, 43 years of age, weighting 94.80 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, extradural abscess, hydrocephalus
, intracranial hypotension, metabolic acidosis, pancytopenia, wound infection. Temodal dosage: 150 MG/M2; QD; PO; 150 MG/M2; QD; PO; 150 MG/M2; QD; PO. During the same period patient was treated with ZOFRAN, LOXONIN, POSTERISANTE, DEPAKENE, PREDNISOLONE, MUCOSTA. Patient died on 05/21/2007.Temodal Side Effects Report #5937820-8
Temodal side effect was reported by a Consumer or non-health professional from JAPAN on Oct 24, 2008. Male patient, 43 years of age, weighting 180.8 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bedridden, cerebral infarction, disease progression, glioblastoma multiforme, paralysis
. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with KYTRIL, ALEVIATIN, CELESTONE, TEGRETOL. Patient died.Temodal Side Effects Report #5643080-8
Temodal side effect was reported by a Physician from JAPAN on Feb 18, 2008. Male patient, 38 years of age, weighting 119.0 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: aphagia, disease progression, glioblastoma multiforme, hepatic function abnormal, herpes virus infection, nausea
. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with NASEA, WAKOBITAL, BETAMETHASONE, GLYCEOL. Patient was hospitalized. Patient died on 03/17/2007.Temodal Side Effects Report #6120779-0
Temodal side effect was reported by a Physician from JAPAN on Mar 06, 2009. Male patient, 34 years of age, weighting 123.5 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: convulsion, disease progression, glioblastoma multiforme, scotoma. Temodal dosage: unknown. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5533795-4
Temodal side effect was reported by a Physician from JAPAN on Nov 26, 2007. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with glioblastoma multiforme, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, gastric cancer, neoplasm progression, platelet count decreased. Temodal dosage: 220 MG/M2;QD;PO; 340 MG/M2;QD;PO. During the same period patient was treated with BAKTAR. Patient died on 08/17/2007.
Temodal Side Effects Report #5701433-3
Temodal side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 33 years of age, weighting 132.3 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, gastric cancer, glioblastoma multiforme, hepatic function abnormal, neutrophil count decreased, platelet count decreased. Temodal dosage: 220 MG/M2; QD; PO, 340 MG/M2; QD; PO, 340 MG/M2; QD; PO, 340 MG/M2; QD; PO. During the same period patient was treated with BAKTAR, ZOFRAN ZYDIS. Patient was hospitalized. Patient died on 08/17/2007.
Temodal Side Effects Report #5884629-X
Temodal side effect was reported by a Physician from JAPAN on Sept 09, 2008. Female patient, 32 years of age, weighting 127.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: candidiasis, condition aggravated, culture stool positive, dehydration, diarrhoea, disease progression, enteritis infectious, enterobacter infection, enterococcal infection. Temodal dosage: 75 MG/M2; QD; PO, 150 MG/M2; QD; PO, 200 MG/M2; QD; PO. During the same period patient was treated with DEPAKENE. Patient died on 09/17/2007.
Temodal Side Effects Report #5929272-9
Temodal side effect was reported by a Health Professional from TURKEY on Oct 10, 2008. Male patient was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, off label use, pulmonary oedema. Temodal dosage: unknown. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #6024299-3
Temodal side effect was reported by a Physician from JAPAN on Dec 16, 2008. Female patient, weighting 138.9 lb, was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: altered state of consciousness, disease progression, hemiparesis, hepatic function abnormal, neoplasm progression, speech disorder. Temodal dosage: 75 MG/M2; QD; PO, 150 MG/M2; QD;PO, 200 MG/M;QD/PO. Patient died on 01/20/2008.
Temodal Side Effects Report #6099542-5
Temodal side effect was reported by a Physician from JAPAN on Feb 24, 2009. Male patient was diagnosed with glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, disease progression, hepatic function abnormal, platelet count decreased. Temodal dosage: 150 MG/M2; QD; PO. During the same period patient was treated with INTERFERON. Patient was hospitalized. Patient died on 06/01/2008.
Temodal Side Effects Report #5656219-5
Temodal side effect was reported by a Consumer or non-health professional from FRANCE on Feb 29, 2008. Female patient, 83 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, glioblastoma. Temodal dosage: 150 MG/M2; ; PO, 200 MG/M2; ; PO. Patient died on 10/10/2007.
Temodal Side Effects Report #5225629-2
Temodal side effect was reported by a Physician from GERMANY on Jan 21, 2007. Male patient, 71 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: arrhythmia
, cerebral haemorrhage, diabetes mellitus inadequate control, disease progression, pneumonia , shock. Temodal dosage: 300 MG; QD; PO. During the same period patient was treated with BELOC ZOK MITE, DECORTIN, EUGLUCON. Patient was hospitalized. Patient died on 10/30/2006.Temodal Side Effects Report #5874887-X
Temodal side effect was reported by a Physician from GERMANY on Aug 29, 2008. Male patient, 71 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, clostridial infection, condition aggravated, disease progression, epstein-barr virus infection, glioblastoma. Temodal dosage: MG; QD; PO. During the same period patient was treated with ZOFRAN, NOVALGIN, COTRIM, NEXIUM, DEXAMETHASONE. Patient was hospitalized. Patient died on 08/17/2008.
Temodal Side Effects Report #5766490-7
Temodal side effect was reported by a Physician from GERMANY on June 02, 2008. Female patient, 67 years of age, weighting 187.4 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, glioblastoma, hallucination, visual, neoplasm recurrence, sleep disorder
. Temodal dosage: 260 MG; QD; PO. Patient was hospitalized. Patient died on 01/05/2008.Temodal Side Effects Report #5859192-X
Temodal side effect was reported by a Physician from AUSTRALIA on Aug 19, 2008. Female patient, 66 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow transplant
, disease progression, fungal sepsis, liver abscess, lung abscess, lymphoma , neutropenia, pelvic abscess. Temodal dosage: 140 MG QD PO. During the same period patient was treated with SEPTRA DS, THYROXINE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5897662-9
Temodal side effect was reported by a Physician from AUSTRALIA on Sept 18, 2008. Female patient, 66 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: aspergillosis, bone marrow failure, bone marrow transplant
, disease progression, fungal sepsis, liver abscess, neutropenia, pelvic abscess, pseudomonas infection. Temodal dosage: 140 MG;QD;PO. During the same period patient was treated with SEPTRA DS, LEVOTHYROXINE, OMEPRAZOLE. Patient was hospitalized. Patient recovered.Temodal Side Effects Report #5422974-2
Temodal side effect was reported by a Physician from JAPAN on Aug 13, 2007. Female patient, 65 years of age, weighting 136.7 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: cardiac failure, disease progression, wheezing. Temodal dosage: 75 MG/M2;QD;PO; 150 MG/M2;QD;PO; 200 MG/M2;QD;PO. During the same period patient was treated with BAKTAR, NAUZELIN, MAGMITT, PREDONINE, LANSOPRAZOLE. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #5445958-7
Temodal side effect was reported by a Physician from JAPAN on Aug 29, 2007. Male patient, 65 years of age, weighting 138.9 lb, was diagnosed with glioblastoma, recurrent cancer and was treated with Temodal. After drug was administered, patient experienced the following side effects: depressed level of consciousness, disease progression, interstitial lung disease, multi-organ failure, pneumocystis jiroveci pneumonia. Temodal dosage: 150 MG/M2; QD; PO, 150 MG/M2; QD; PO, 150 MG/M2; QD; PO. During the same period patient was treated with EXCEGRAN, DEPAKENE, IRINOTECAN. Patient died on 03/07/2007.
Temodal Side Effects Report #5449329-9
Temodal side effect was reported by a Physician from GERMANY on Sept 03, 2007. Female patient, 62 years of age, weighting 156.5 lb, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, c-reactive protein increased, disease progression, gamma-glutamyltransferase increased, hypersensitivity, neoplasm recurrence. Temodal dosage: 75 MG/M2;. During the same period patient was treated with RAMIPRIL, LEVOTHYROXINE, PREDNISOLONE. Patient recovered.
Temodal Side Effects Report #5729622-2
Temodal side effect was reported by a Physician from FRANCE on Apr 24, 2008. Female patient, 57 years of age, was diagnosed with glioblastoma and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, febrile bone marrow aplasia, thrombocytopenia. Temodal dosage: unknown. Patient died.
Temodal Side Effects Report #5613332-6
Temodal side effect was reported by a Physician from GERMANY on Jan 21, 2008. Male patient, 37 years of age, weighting 253.5 lb, was diagnosed with glioblastoma, brain oedema and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, disease progression, gamma-glutamyltransferase increased. Temodal dosage: 220 MG;QD. During the same period patient was treated with ZOFRAN, PANTOPRAZOLE, DEXAMETHASONE. Patient was hospitalized. Patient died on 01/12/2008.
Temodal Side Effects Report #5766795-X
Temodal side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on June 03, 2008. Male patient, 58 years of age, weighting 97.00 lb, was diagnosed with gastrointestinal carcinoma, respiratory tract neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: anorexia, asthenia, dehydration, depressed mood, disease progression, feeling abnormal, haemoglobin decreased, neutropenia, weight decreased. Temodal dosage: 150 MG/M2;PO. During the same period patient was treated with METOCLOPRAMIDE, SUCRALFATE, TEMAZEPAM, CLINUTREN, LANSOPRAZOLE, WARFARIN. Patient was hospitalized. Patient recovered.
Temodal Side Effects Report #6094984-6
Temodal side effect was reported by a Physician from JAPAN on Feb 23, 2009. Male patient, 43 years of age, weighting 180.8 lb, was diagnosed with disease recurrence, glioblastoma multiforme and was treated with Temodal. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, cerebral infarction, condition aggravated, disease progression, neoplasm progression, paralysis
. Temodal dosage: 150 MG/M2;QD;PO; 150 MG/M2;QD;PO; 150 MG/M2;QD;PO; 150 MG/M2;QD;PO. During the same period patient was treated with KYTRIL. Patient died.Temodal Side Effects Report #5383506-0
Temodal side effect was reported by a Consumer or non-health professional from CANADA on June 20, 2007. Male patient, 56 years of age, weighting 165.3 lb, was diagnosed with brain neoplasm malignant and was treated with Temodal. After drug was administered, patient experienced the following side effects: brain oedema, disease progression. Temodal dosage: 95 MG; QD; PO. During the same period patient was treated with DILANTIN, TYLENOL, ZOFRAN, MAXERAN, RIVOTRIL, ELOCON. Patient recovered.
Temodal Side Effects Report #5261487-8
Temodal side effect was reported by a Physician from JAPAN on Feb 28, 2007. Male patient, child 6 years of age, weighting 35.27 lb, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: blood urea increased, brain neoplasm, disease progression, hypernatraemia, platelet count decreased, pneumonia bacterial, tumour necrosis, white blood cell count decreased. Temodal dosage: 75 MG/M2;QD;PO. During the same period patient was treated with VEPESID, BAKTAR, LASTET S, NASEA, PRIMPERAN, DECADRON, MANNITOL, LEPETAN. Patient died on 10/26/2006.
Temodal Side Effects Report #5011559-8
Temodal side effect was reported by a Physician from CANADA on May 15, 2006. Male patient, 58 years of age, was diagnosed with brain neoplasm and was treated with Temodal. After drug was administered, patient experienced the following side effects: disease progression, glioma, haemorrhage intracranial, myopathy, nuclear magnetic resonance imaging abnormal. Temodal dosage: 400 MG QD ORAL. During the same period patient was treated with DECADRON, CLOBAZAM, TEGRETOL. Patient died on 04/03/2006.